In the preceding three months, 10 analysts have released ratings for Globe Life (NYSE:GL), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Analysts have recently evaluated Globe Life and provided 12-month price targets. The average target is $112.5, accompanied by a high estimate of $132.00 and a low estimate of $75.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 15.35%.
Investigating Analyst Ratings: An Elaborate Study
A clear picture of Globe Life's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Key Insights:
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Globe Life's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Globe Life analyst ratings.
Delving into Globe Life's Background
A Deep Dive into Globe Life's Financials
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Globe Life's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 7.67%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.59%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Globe Life's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 5.34%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Globe Life's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.9% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Globe Life's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.47.
The Core of Analyst Ratings: What Every Investor Should Know
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
